COMMUNIQUÉS West-GlobeNewswire

KFSHRC’s DCEO Highlights Medical Tourism Growth at Arab Health 2025

28/01/2025 - 16:16

Advanced Tech and Global Collaborations Attract Patients from 17 Countries RIYADH, Saudi Arabia, Jan. 28, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) Deputy Chief Executive [...]

Serotonin Anti-Aging Centers Accelerates National Growth with Five New Locations Opening in Q1 2025

28/01/2025 - 16:19

ORLANDO, Fla., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Serotonin Anti-Aging Centers, the premier anti-aging and longevity med spa franchise, is kicking off 2025 with rapid expansion, opening five new locations in Charleston, [...]

Lytus Technologies Expands Its Footprint into Healthcare with Cutting-Edge Patient-Centric HealthTech Platform

28/01/2025 - 16:21

Launches Fully Owned Subsidiary, Lytus HealthTech, with Plans for Significant Investment Mumbai, India, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Lytus Technologies (NASDAQ: LYT), a leader in platform services and next- [...]

Surgery Partners, Inc. Confirms Receipt of Non-Binding Acquisition Proposal from Bain Capital

28/01/2025 - 19:03

BRENTWOOD, Tenn., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ: SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced that its Board [...]

SELLAS Life Sciences Group Announces $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

28/01/2025 - 21:11

NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a [...]

Tevogen Bio Enters Agreement to Receive Up To $10 Million of Non-Dilutive Grant Funding

28/01/2025 - 21:49

The grant funding will further Tevogen Bio’s mission to develop therapies for treatment of cancers and viral infections. Tevogen Bio may also utilize the grant funding to further expand its artificial intelligence [...]

Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Provides a Corporate Update

28/01/2025 - 22:00

R eported a robust objective response rate of 75.5% from the Phase 1 study of NX-5948 in patients with relapsed/refractory CLL/SLL at the 66 th American Society of Hematology Annual Meeting Received PRIME designation [...]

Ascentage Pharma Announces Closing of U.S. Initial Public Offering

28/01/2025 - 22:01

ROCKVILLE, Md. and SUZHOU, China, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (Nasdaq: AAPG) (HKEX: 6855) announced today the closing of its U.S. initial public offering of 7,325,000 American depositary shares (“ [...]

Eyenovia Announces 1-for-80 Reverse Stock Split

28/01/2025 - 22:05

Reverse stock split, when effective, is intended to restore compliance with the Nasdaq minimum bid price requirement while Eyenovia continues to evaluate a broad range of strategic alternatives NEW YORK, Jan. 28, 2025 ( [...]

Stryker reports 2024 operating results and 2025 outlook

28/01/2025 - 22:05

Portage, Michigan, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2024: Fourth Quarter Results Reported net sales increased 10.7% to $6.4 billion [...]

Stryker announces the retirement of Glenn S. Boehnlein and the promotion of Preston Wells to Vice President, Chief Financial Officer

28/01/2025 - 22:05

Portage, Michigan, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) announced today that Glenn S. Boehnlein will retire from his role as Vice President, Chief Financial Officer. Boehnlein’s decision follows an [...]

Stryker announces definitive agreement for the sale of its U.S. spinal implants business and plans to sell related international business

28/01/2025 - 22:05

Portage, Michigan, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK), a global leader in medical technologies, announced today a definitive agreement to sell its U.S. spinal implants business to Viscogliosi Brothers [...]

Zentalis Pharmaceuticals Announces Strategic Restructuring to Support Late-Stage Azenosertib Development

28/01/2025 - 22:05

Extended cash runway into late 2027, beyond a potentially registration-enabling azenosertib data readout from DENALI Part 2 Planned workforce reduction of approximately 40% of employees Corporate event to be held on [...]

ANI Pharmaceuticals to Present at the Guggenheim Biotech Conference

28/01/2025 - 22:30

PRINCETON, N.J., Jan. 28, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that Nikhil Lalwani, President and Chief Executive Officer, and Stephen Carey, Chief [...]

YuzuYello Named an Ad Age Best Place to Work 2025

28/01/2025 - 22:41

IPG Health agency honored with third recent noteworthy culture-focused award NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Yesterday, YuzuYello, an IPG Health company, announced that it has earned a top spot on Ad Age’s [...]

Acuitive Technologies, Inc. Appoints Dr. Wayne Berberian as Chief Medical Officer

27/01/2025 - 14:00

Acuitive Technologies announces the appointment of Dr. Wayne Berberian as Chief Medical Officer. In this role, Dr. Berberian will drive the company’s strategy behind new product development of first-in-class [...]

Entera Bio to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

27/01/2025 - 14:00

JERUSALEM, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides and therapeutic proteins, announced that it will [...]

iCAD Pre-Announces Estimated Q4 2024 Revenue

27/01/2025 - 14:00

iCAD to Participate in the BTIG at Snowbird: 12 th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference NASHUA, N.H., Jan. 27, 2025 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the [...]

Stereotaxis Receives CE Mark Approval for the MAGiC Ablation Catheter

27/01/2025 - 14:00

ST. LOUIS, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it received European CE Mark [...]